Clinical Trial Results

Showing: All studies [change]
Condition: Lupus Location: Fullerton, California 25 trials found
New Search
Filter
Trial Phase
Study Type
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
PHASE1INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
FT839 in Autoimmune Diseases
PHASE1, PHASE2INTERVENTIONAL Fullerton, California
RECRUITING
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
PHASE2INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
PHASE1, PHASE2INTERVENTIONAL Orange, California +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Avondale, Arizona +4 more
RECRUITING
VIBRANT: VIB4920 for Active Lupus Nephritis
PHASE2INTERVENTIONAL La Jolla, California +4 more
RECRUITING
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
N/AOBSERVATIONAL La Jolla, California +4 more
RECRUITING
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
PHASE1, PHASE2INTERVENTIONAL La Palma, California +4 more
RECRUITING
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
PHASE2INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
PHASE4INTERVENTIONAL La Mesa, California +4 more
RECRUITING
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
PHASE1INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
PHASE1, PHASE2INTERVENTIONAL Little Rock, Arkansas +4 more
RECRUITING
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
PHASE1INTERVENTIONAL Apple Valley, California +4 more
RECRUITING
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Lupus Landmark Study: A Prospective Registry and Biorepository
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
PHASE3INTERVENTIONAL Upland, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type